Document is current

Article History

Received: 20 November 2024

Accepted: 26 February 2025

First Online: 18 March 2025

Declarations

:

: Each study was approved by the local ethics committee of the participating centers, including the ethics committee of LMU Munich (project numbers 17–755 and 17–569). Patients with early AD (subjective cognitive impairment, MCI and mild AD dementia) and age-matched cognitively normal controls were included after providing written informed consent in line with the declaration of Helsinki.

: The DELCODE Study Group comprises investigators from multiple sites who have contributed to the design, data acquisition, or analysis of the DELCODE study. Specific authors listed in the main author list (Julian Hellmann-Regen10,11,12, Josef Priller10,14,15,16, Anja Schneider17,18, Frank Jessen17,19,20, Emrah Düzel21,22, Katharina Buerger4,23, Stefan Teipel24,25, Christoph Laske26,27, Oliver Peters10,13, Eike Spruth10,14, Klaus Fliessbach17,18, Ayda Rostamzadeh19, Wenzel Glanz21, Daniel Janowitz23, Ingo Kilimann24,25, Sebastian Sodenkamp26,28, Michael Ewers4,23) are also part of the DELCODE consortium.

: Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: .

: Not applicable.

: The authors declare no competing interests.

: The authors have nothing to disclose.